Estrogen Modulation of Opioid and Cholecystokinin Systems in the Limbic-Hypothalamic Circuit

Adan, 1992, Regulation of vasopressin and oxytocin gene expression by estrogen and thyroid hormone, Prog. Brain Res., 92, 127, 10.1016/S0079-6123(08)61169-3 Akesson, 1987, Estrous cyclicity of 125I-cholecystokinin octapeptide binding in the ventromedial hypothalamic nucleus, Neuroendocrinology, 45, 257, 10.1159/000124737 Akesson, 1991, Endogenous opioid-immunoreactive neurons of the ventromedial hypothalamic nucleus concentratre estrogen in male and female rats, J. Neurosci Res., 28, 359, 10.1002/jnr.490280307 Akesson, 1988, Evidence for an absence of estrogen concentration by CCK-immunoreactive neurons in the hypothalamus of the female rat, J. Neurobiol., 19, 3, 10.1002/neu.480190103 Allen, 1985, Naltrexone facilitation of sexual receptivity in the rat, Horm. Behav., 19, 98, 10.1016/0018-506X(85)90010-8 Babcock, 1988, Injections of cholecystokinin into the ventromedial hypothalamic nucleus inhibit lordosis behavior in the rat, Physiol. Behav., 43, 195, 10.1016/0031-9384(88)90237-5 Benoliel, 1991, Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation, Neurosci. Lett., 124, 204, 10.1016/0304-3940(91)90094-A Caron, 1993, Catecholamine receptors, Recent Prog. Horm. Res., 48, 277, 10.1016/B978-0-12-571148-7.50014-2 Clarke, 1979, Opiate inhibition of peptide release from the neurohumoral terminals of hypothalamic neurones, Nature, 282, 746, 10.1038/282746a0 Dado, 1993, Immunofluorescent identification of a δ-opioid receptor on primary afferent nerve terminals, Neuroreport, 5, 341, 10.1097/00001756-199312000-00041 DeBold, 1994, Genomic and non-genomic actions of progesterone in the control of female hamster sexual behavior, Horm. Behav., 28, 445, 10.1006/hbeh.1994.1042 Dellovade, 1995, Potential interactions between estrogen receptor and thyroid receptors relevant for neuroendocrine systems, J. Steroid Biochem. Mol. Biol., 53, 27, 10.1016/0960-0760(95)00037-Z Dornan, 1989, Microinjection of cholecystokinin into the medial preoptic nucleus facilitates lordosis behavior in the female rat, Physiol. Behav., 45, 969, 10.1016/0031-9384(89)90223-0 Dourish, 1988, Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718, Eur. J. Pharmacol., 147, 469, 10.1016/0014-2999(88)90183-5 Drouva, 1985, Effects of 17β-estradiol on LHRH release from rat mediobasal hypothalamic slices, Neuroendocrinology, 38, 152, 10.1159/000123883 Dupont, 1980, β-Endorphin and metenkephalins, Fed. Proc., 39, 2544 Eckersell, 1997, Opiate receptor modulation of estrogen-induced cholecystokinin and tachykinin mRNA but not enkephalin mRNA levels in the limbic system and hypothalamus, Neuroscience, 80, 473, 10.1016/S0306-4522(97)00072-9 Eckersell, 1996, Stress up-regulates preproenkephalin (PPE) mRNA levels in the limbic system and hypothalamus of the female rat, Soc. Neurosci. Abstr., 22, 1415 Eckersell, 1994, Temporal regulation of preproenkephalin-A mRNA expression by estrogen in the posterior dorsal medial amygdala of the female rat, Soc. Neurosci. Abstr., 20, 1770 Elde, 1995, Distribution of neuropeptide receptors, New views of peptidergic neurotransmission made possible by antibodies to opioid receptors. Ann. NY Acad. Sci., 757, 390 Faris, 1986, Increase in hypothalamic cholecystokinin following acute and chronic morphine, Brain Res., 367, 405, 10.1016/0006-8993(86)91629-X Faris, 1983, Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia, Science, 219, 310, 10.1126/science.6294831 Felicio, 1991, Intracerebroventricular cholecystokinin infusions block β-endorphin-induced disruption of maternal behavior, Pharmacol. Biochem. Behav., 39, 201, 10.1016/0091-3057(91)90422-X Glass, 1988, The thyroid hormone receptor binds with opposite transcriptional effects to a common sequence motif in thyroid hormone and estrogen response elements, Cell, 54, 313, 10.1016/0092-8674(88)90194-8 Grady, 1995, Delineation of the endocytic pathway of substance P and its seven-transmembrane domain NK1 receptor, Mol. Biol. Cell., 6, 509, 10.1091/mbc.6.5.509 Hammer, 1991, Differential localization of opioid neurons projecting to the medial preoptic nucleus, Anat. Rec., 229, 35A Hammer, 1995, Sex steroid regulation of hypothalamic opioid function, 143 Han, 1985, Is cholecystokinin octapeptide (CCK-8) a candidate for endogenous anti-opioid substrates?, Neuropeptides, 5, 399, 10.1016/0143-4179(85)90038-1 Harrison, 1989, Rapid actions of steroids on CNS neurons, 137 Herbison, 1992, Localization of oestrogen receptors in preoptic neurons containing neurotensin but not tyrosine hydroxylase, cholecystokinin or luteinizing hormone-releasing hormone in the male and female rat, Neuroscience, 50, 283, 10.1016/0306-4522(92)90423-Y Hill, 1989, Electrophysiological actions of CCK in the mammalian central nervous system, 186 Hill, 1987, Antinociceptive action of cholecystokinin octapeptide (CCK-8) and related peptides in rats and mice, Neuropharmacology, 26, 289, 10.1016/0028-3908(87)90180-8 Holland, 1996, Estrogen stimulates cholecystokinin and preproenkephalin mRNA in the female limbic-hypothalamic circuit during the peripubertal period, Soc. Neurosci. Abstr., 22, 561 Holland, K. L.; Popper, P.; Micevych, P. E. Antisense oligodeoxynucleotides to CCK-A receptor mRNA inhibit lordosis behavior. Physiol. Behav. (in press). Honda, 1993, Differential gene expression of CCK-A and CCK-B receptors in the rat brain, Mol. Cell. Neurosci., 4, 143, 10.1006/mcne.1993.1018 Hoxie, 1993, Internalization and recycling of activated thrombin receptors, J. Biol. Chem., 268, 13756, 10.1016/S0021-9258(18)86921-6 Igwe, 1994, Modulation of substance P-ergic system in the rat spinal cord by an opioid antagonist, Mol. Brain Res., 21, 263, 10.1016/0169-328X(94)90257-7 Jacobson, 1989, Decreases in mediobasal hypothalamic and preoptic area opioid ([3H]naloxone) binding are associated with the progesterone-induced luteinizing hormone surge, Endocrinology, 124, 199, 10.1210/endo-124-1-199 Jessell, T. M.; Iversen, L. L. Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature 268:549–151; 1977. Keith, 1995, Rapid endocytosis of opioid receptors, Soc. Neurosci. Abstr., 21, 1353 Kelly, 1992, Estrogen suppresses μ-opioid- and GABAB-mediated hyperpolarization of hypothalamic arcuate neurons, J. Neurosci., 12, 2745, 10.1523/JNEUROSCI.12-07-02745.1992 Lagrange, 1995, Estradiol-17β and μ-opioid peptides rapidly hyperpolarize GnRH neurons, Endocrinology, 136, 2341, 10.1210/en.136.5.2341 Lagrange, 1994, The potency of μ-opioid hyperpolarization of hypothalamic arcuate neurons is rapidly attenuated by 17β-estradiol, J. Neurosci., 14, 6196, 10.1523/JNEUROSCI.14-10-06196.1994 Li, 1992, Cholecystokinin, Neuroscience, 48, 707, 10.1016/0306-4522(92)90413-V Lutz, 1992, Opioid receptors and their pharmacological profiles, J. Recept. Res., 12, 267, 10.3109/10799899209074796 Mansour, 1994, μ, δ and κ delta opioid receptor mRNA expression in the rat CNS, J. Comp. Neurol., 350, 412, 10.1002/cne.903500307 Mansour, 1988, Anatomy of CNS opioid receptors, Trends Neurosci., 11, 308, 10.1016/0166-2236(88)90093-8 Mansour, 1993, Delta opioid receptor mRNA ditribution in the brain, J. Chem. Neuroanat., 6, 351, 10.1016/0891-0618(93)90010-2 Mantyh, 1995, Rapid endocytosis of a G protein-coupled receptor, Proc. Natl. Acad. Sci. USA, 92, 2622, 10.1073/pnas.92.7.2622 Mantyh, P. W.; DeMaster, E.; Malhotra, A.; Ghilardi, J. R.; Rogers, S. D.; Mantyh, C. R.; Liu, H.; Basbaum, A. I.; Vigna, S. R.; Maggio, J.E.; et al. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science 268:1629–1232; 1995. Mateo, 1992, ; Jr, Dynamic patterns of medial preoptic μ-opiate receptor regulation by gonadal steroid hormones. Neuroendocrinology, 55, 51 Micevych, 1982, , Yaksh, T, L., Go, V. L. W. Opiate-mediated inhibition of the release of cholecystokinin and substance P, but not neurotensin from cat hypothalamic slices. Brain Res., 250, 283 Micevych, 1994, Gonadal steroid control of preprocholecystokinin mRNA expression in the limbic–hypothalamic circuit, J. Neurosci. Res., 38, 386, 10.1002/jnr.490380404 Micevych, 1994, Gonadal steroid control of preproenkephalin mRNA expression in the limbic–hypothalamic circuit, J. Neorosci. Res., 38, 386, 10.1002/jnr.490380404 Micevych, 1988, Distribution of cholecystokinin-immunoreactive cell bodies in the male and female rat, Bed nucleus of the stria terminalis and amygdala. J. Comp. Neurol., 269, 381, 10.1002/cne.902690306 Micevych, P. E.; Block, G. J. Estrogen regulation of a reproductively relevant cholecystokinin circuit in the hypothalamus and limbic system of the rat. In: Hughes, J.; Dockray, G.; Woodruff, G. eds. The neuropeptide cholecystokinin (CCK); New York: John Wiley; 1989:68–73. Micevych, 1996, Induction of CCK mRNA levels in the limbic–hypothalamic circuit, J. Neurobion., 30, 465, 10.1002/(SICI)1097-4695(199608)30:4<465::AID-NEU3>3.0.CO;2-1 Micevych, 1995 Micevych, 1988, Concentrations of cholecystokinin, substance P, and bombesin in discrete regions of male and female rat brain, Exp. Neurol., 100, 416, 10.1016/0014-4886(88)90119-7 Micevych, 1987, Distribution of cholecystokinin-immunoreactive cell bodies in the male and female rat, Hypothalamus. J. Comp. Neurol., 255, 124, 10.1002/cne.902550110 Micevych, 1992, Development of the limbic–hypoythalamic cholecystokinin circuit, Dev. Neurosci., 14, 11, 10.1159/000111643 Micevych, 1982, In vitro release of cholecystokinin from hypothalamus and frontal cortex of Sprague–Dawley, Zucker lean (Fa/−) and obese (fa/fa) rats, Peptides, 5, 73, 10.1016/0196-9781(84)90054-8 Micevych, P. E.; Yaksh, T. L.; Go, V. W.; Finkelstein, J. A. Effect of opiates on the release of cholecystokinin from in vitro hypothalamus and frontal cortex of Zucker lean (Fa/−) and obese (fa/fa) rats. Brain Res. 337:382–305; 1985. Moran, 1986, , Robinson, P, H., Goldrich, M. S.; McHugh, P. R. Two brain cholecystokinin receptors: Implications for behavioral actions. Brain Res., 362, 175 Noble, 1993, Modulation of opioid antinociception by CCK at the supraspinal level, Br. J. Pharmacol., 109, 1064, 10.1111/j.1476-5381.1993.tb13730.x O’Neill, 1989, Morphine-induced analgesia in the rat paw pressure test is blocked by CCK and enhanced by the CCK-antagonist MK-329, Neuropharmacology, 28, 243, 10.1016/0028-3908(89)90099-3 Ossipov, 1994, Naltrindole, an opioid δ antagoinist, blocks the enhancement of morphine-antinoceception induced by a CCKB antagonist in the rat, Neurosci. Lett., 181, 9, 10.1016/0304-3940(94)90548-7 Pfaff, D. W., Schwartz–Giblin, S., McCarthy, M.; Kow, L.-M. Cellular and molecular reproductive behaviors. In: Knobil E.; Neill J.D., eds. The physiology of Reproduction, vol. 2. New York: Raven Press, Ltd.; 1994:107–220. Pfaff, 1985, Neural mechanisms of female reproductive behaviors, 423 Pfaff, 1995, Interactions of estrogen and thyroid hormone on the regulation of preproenkephalin (PPE) gene expression in the hypothalamus and striatum of female rats, Soc. Neurosci. Abstr., 21, 189 Pfaus, 1992, μ,δ and κ-opioid receptor agonists selectively modulate sexual behaviors in the female rat, Horm. Behav., 26, 457, 10.1016/0018-506X(92)90014-M Popper, 1995, Effects of sex steroids on the cholecystokinin circuit modulating reproductive behavior, 160 Priest, 1997, Estrogen and stress interact to regulate the hypothalamic expression of a human proenkephalin promoter-β-galactosidase fusion gene in a site-specific and gender-specific manner, J. Neuroendocrinol., 9, 317, 10.1046/j.1365-2826.1997.00589.x Priest, 1995, Estrogen regulates preproenkephalin-A mRNA levels in the rat ventromedial nucleus, Mol. Brain Res., 28, 251, 10.1016/0169-328X(94)00213-X Pu, 1994, Cholesystokinin gene expression in rat amygdaloid neurons, Mol. Brain Res., 21, 183, 10.1016/0169-328X(94)90249-6 Romano, 1988, Estrogen increases proenkephalin messenger ribonucleic acid levels in the ventromedial hypothalamus of the rat, Mol. Endocrinol., 2, 1320, 10.1210/mend-2-12-1320 Romano, 1989, Estrogen regulation of proenkephalin gene expression in the ventromedial hypothalamus of the rat, Mol. Brain Res., 5, 51, 10.1016/0169-328X(89)90017-X Schumacher, 1991, Binding of [3H]cholecystokinin in the ventromedial hypothalamus is modulated by an afferant brainstem projection but not by ovarian steroids, Brain Res., 564, 102, 10.1016/0006-8993(91)91358-8 Simon, 1991, Opioid receptors and endogenous opioid peptides, Med. Res. Rev., 11, 357, 10.1002/med.2610110402 Sirinathsinghji, 1986, Regulation of lordosis behavior in the female rat by corticotropin-releasing factor, beta-endorphin/corticotropin and luteinizing hormone-releasing hormone neuronal systems in the medial preoptic area, Brain Res., 375, 149, 10.1016/0006-8993(86)90957-1 Sternini, 1996, Agonist selective endocytosis of μ-opioid receptor by neurons in vivo, Proc. Natl. Acad. Sci. USA, 93, 9241, 10.1073/pnas.93.17.9241 Suh, 1990, Differential effects of sulfated cholecystokinin octapeptide and proglumide injected intrathecally on antinociception induced by β-endorphin and morphine administered intracerebroventricularly in mice, Eur. J. Pharmacol., 179, 329, 10.1016/0014-2999(90)90173-4 Tischkau, 1993, A specific membrane binding protein for progesterone in rat brain, Proc. Natl. Acad. Sci. USA, 90, 1285, 10.1073/pnas.90.4.1285 Trowbridge, 1993, Signal-dependent membrane protein trafficking in the endocytic pathway, Annu. Rev. Cell Biol., 9, 129, 10.1146/annurev.cb.09.110193.001021 Ulibarri, 1993, Role of perinatal estrogens in sexual differentiation of the inhibition of lordosis by exogenous cholecystokinin, Physiol. Behav., 54, 95, 10.1016/0031-9384(93)90049-L von Zastrow, 1992, Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors, J. Biol. Chem., 267, 3530, 10.1016/S0021-9258(19)50762-1 Wank, 1992, Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas, Proc. Nat. Acad. Sci. USA, 89, 3125, 10.1073/pnas.89.7.3125 Waterman, 1988, A single domain of the estrogen receptor confers deoxyribonucleic acid binding and transcriptional activation of the rat prolactin gene, Mol. Endocrinol., 2, 14, 10.1210/mend-2-1-14 Watkins, 1985, Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates, Brain Res., 327, 181, 10.1016/0006-8993(85)91512-4 Wiesner, 1986, Behavioral specificity of beta-endorphin suppression of sexual behavior, Pharmacol. Biochem. Behav., 24, 1235, 10.1016/0091-3057(86)90177-2 Wiesner, 1986, Suppression of receptive and proceptive behavior in ovariectomized, estrogen-progesterone-primed rats by intraventricular β-endorphin, Neuroendocrinology, 43, 57, 10.1159/000124509 Wilcox, 1985, Estrogen decreases rat hypothalamic proopiomelanocortin messenger ribonucleic acid levels, Endocrinology, 117, 2392, 10.1210/endo-117-6-2392 Wilkinson, 1985, Gonadal steroid-induced modification ofopiate binding sites in anterior hypothalamus of female rats, Biol. Reprod., 32, 501, 10.1095/biolreprod32.3.501 Yaksh, 1986, The central pharmacology of primary afferents and emphasis of the disposition and role of primary afferent substance P, 165 Zaborsky, 1984, Brainstem projection to the hypothalamic ventromedial nucleus in the rat, Brain Res., 303, 225, 10.1016/0006-8993(84)91208-3 Zhou, 1993, Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of μ-opioid analgesia by CCK-B receptor antagonist L-365,260 in rat spinal cord, Euro. J. Pharmacol., 234, 147, 10.1016/0014-2999(93)90948-H